United States · Biotechnology startup
United States · Character Biosciences
Character Biosciences is a precision medicine company founded between 2018 and 2019, focusing on transforming drug development for progressive, polygenic diseases, particularly in ophthalmology.
Funding reportedLast round: Series A
Follow Character Biosciences and see its new rounds in your feed.Start following
About Character Biosciences
Character Biosciences is a precision medicine company founded between 2018 and 2019, focusing on transforming drug development for progressive, polygenic diseases, particularly in ophthalmology.
Formerly known as Clover Therapeutics, the company utilizes an AI-powered platform that integrates genomics, clinical data, and machine learning to identify genetic and molecular drivers of disease progression. This approach aims to develop targeted therapies for patients with urgent unmet needs. Headquartered in Jersey City, New Jersey, with additional operations in California and Brisbane, Character Biosciences operates a drug discovery platform that partners with over 150 ophthalmology clinics. The company is advancing its lead programs, CTX114 and CTX203, which target dry Age-Related Macular Degeneration (AMD) and Primary Open-Angle Glaucoma (POAG). Both programs are in preclinical stages, aiming to deliver more precise and effective therapies for these conditions. Character Biosciences has raised at least $93 million in Series B funding to support its clinical trial advancements.
What company datasets say Character Biosciences raised
Funding, as reported
On 3 portfolio pages
Investors who name them
Each firm lists Character Biosciences on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Known for
health carepersonalized ophthalmologyai-enabled biomarkerscomputer & network securityinformation technology & servicesdata securitygenetic pathwaysdisease subtypingdisease progressionhospital & health caremedicalpatient stratificationtherapeutic developmenthealthbiotechnologyretinal imaging biomarkers
Built with from their website
Amazon SESAmazon CloudFrontGoogle SheetsAtlassianGoogle CloudExpensifyFlowIntel NiosCloudflare DNSGoogle Workspace
+8 more
Zoom MeetingsOloCloudFlareElectronViewport MetaGoogle AnalyticsHTTP/3Amazon Simple Email Service
- Sector
- Biotechnology
- Industry code
- NAICS 541714, SIC 8731
- Region
- California
- Revenue
- $1.0M a year, as listed
- Full record
- Every detail in the company directory
Biotechnology in United States
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Character Biosciences in front of investors. Or tell us what we have wrong.